Most states aren’t adequately prepared to distribute the leading coronavirus vaccine, especially to rural areas, once it is approved for public use, according to a ProPublica analysis of state plans.
Pfizer announced Monday that the coronavirus vaccine it is developing was more than 90% effective and did not produce safety concerns during its large-scale trial. But, as the vaccine approached Food and Drug Administration approval, a ProPublica investigation found that states aren’t ready to administer the delivery of the vaccine to vast swaths of their populations.
“Early, when we don’t have lots of doses, I frankly do not anticipate that vaccine will be widely available in every rural community,” Centers for Disease Control and Prevention’s Vaccine Task Force Chief Medical Officer Dr. Amanda Cohn said on Nov. 3, according to ProPublica.
“The first couple months will be not ideal, but we really want to listen to our rural partners and understand what we can do to make it better,” she continued. (RELATED: ‘You Do The Math’: Vince Coglianese Targets Pfizer’s Timing On COVID-19 Vaccine Announcement)
There are a variety of requirements that officials must meet to ship and store Pfizer’s vaccine, making it difficult for many